Trials / Unknown
UnknownNCT01910584
Quality of Life and Sexual Function of the Novasure Endometrial Ablation in Menorrhagia
Prospective Study of the Influence on Quality of Life and Sexual Function of the Novasure Endometrial Ablation in the Treatment of Menorrhagia
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Shu-Qin Chen · Academic / Other
- Sex
- Female
- Age
- 25 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to investigate the influence on the quality of life and sexual function before, 6 month and one year after Novasure Endometrial Ablation in the treatment of Menorrhagia.
Detailed description
patients diagnosed menorrhagia scheduled for Novasure Endometrial Ablation because of menorrhagia between november, 2012 and november, 2014 are enrolled to this study. patients are asked to complete preoperative questionnaires considering Health Related Quality of Life questionnaire(HRQoL) and sexual Female Sexual Functioning Index questionnaire(FSFI). Same questionnaires will also be completed six months and one year after operation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Novasure endometrial ablation | Novasure endometrial ablation is the second generation endometrial ablation treatment aimed to cure the dysfunctional uterine bleeding(DUB),including menorrhagia. |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2015-11-01
- Completion
- 2015-11-01
- First posted
- 2013-07-29
- Last updated
- 2013-07-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01910584. Inclusion in this directory is not an endorsement.